Country: Malta
Language: English
Source: Medicines Authority
DEXKETOPROFEN
Menarini International Operations Luxembourg S.A 1 Avenue de la Gare, L-1611, Luxembourg
M01AE17
DEXKETOPROFEN 12.5 mg
FILM-COATED TABLET
DEXKETOPROFEN 12.5 mg
OTC
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
Withdrawn
2013-09-27
Page 1 of 6 PACKAGE LEAFLET: INFORMATION FOR THE USER KERAL 12.5 MG FILM-COATED TABLETS _ _ DEXKETOPROFEN READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. Keep this leaflet. You may need to read it again. Ask your pharmacist if you need more information or advice. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. You must talk to a doctor if you do not feel better or if you feel worse after 3-4 days WHAT IS IN THIS LEAFLET: 1. What Keral is and what it is used for 2. What you need to know before you take Keral 3. How to take Keral 4. Possible side effects 5. How to store Keral 6. Contents of the pack and other information 1. WHAT KERAL IS AND WHAT IT IS USED FOR Keral is a pain killer from the group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It is used to treat mild to moderate pain, such as muscular pain, painful periods (dysmenorrhoea), toothache. You must talk to a doctor if you do not feel better or if you feel worse after 3-4 days. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE KERAL DO NOT TAKE KERAL: If you are allergic to dexketoprofen or any of the other ingredients of this medicine (listed in section 6); If you are allergic to acetylsalicylic acid or to other non-steroidal anti-inflammatory medicines; If you have asthma or have suffered attacks of asthma, acute allergic rhinitis (a short period of inflamed lining of the nose), nasal polyps (lumps wit Read the complete document
_ _ Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT KERAL 12.5 mg film-coated tablets KERAL 25 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: dexketoprofen 12.5 mg or 25 mg as dexketoprofen trometamol. For the full list of_ _excipients, see section_ _6.1. 3. PHARMACEUTICAL FORM Film coated tablet. KERAL 12.5 mg: white, round film-coated tablets. KERAL 25 mg: white, round, scored film-coated tablets. The tablets can be divided into equal halves_._ 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Symptomatic treatment of pain of mild to moderate intensity, such as musculo-skeletal pain, dysmenorrhoea, dental pain. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION Posology_ _ _Adults: _ According to the nature and severity of pain, the recommended dosage is generally 12.5 mg every 4-6 hours or 25 mg every 8 hours. The total daily dose should not exceed 75 mg. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). KERAL tablets are not intended for long term use and the treatment must be limited to the symptomatic period. _Paediatric population: _ KERAL has not been studied in children and adolescent. Therefore the safety and efficacy in children and adolescents have not been established and the product should not be used in children and adolescent. _ _ _Older people: _ In elderly patients it is recommended to start the therapy at the lower end of the dosage range (50 mg total daily dose). The dosage may be increased to that recommended for the general populati Read the complete document